•
What
may be the causes of thrombocytopenia in Pregancy?? Ans :The most cases is HELLP which means Hemolysis,
elevated liver enzymes, and low platelet (HELLP) syndrome . HELLP) syndrome is the most common pathologic cause of maternal thrombocytopenia. Members
participation please .
•
•
•
For
Junior members only Prevalence of HELLP ??
.How many of us keep HELLP in D/D of PPH and we continue to administer we
oxytocics ,Balloon or PPH canula as discovered by friend Dr Samrath but withput
any effect, So any case of intrapartum and or PPH we have to keep HELLP in D/D
. HELLP t occurs in approximately 10% to 20% of women who have severe
preeclampsia and is often an early finding in preeclampsia. Not all PPH are PPH
, To please remember that platelets usually nadir at 24 to 48 hours after
delivery but typically do not drop below 20,000/pLin undiagnosed HELLP .. In
women who remain severely thrombocytopenic after delivery, plasma exchange
and/or corticosteroids may be considered. In addition to improving neonatal
outcome before 34 weeks’ gestation, corticosteroids may also improve maternal
outcomes. When given in the antepartum period, transient improvements are seen
in maternal platelet counts. Small placebo-controlled trials have not shown
decreased morbidity when steroids are continued postpartum.
Antiplatelct antibodies are more dangerous than Coronoa or recent Cyclone that hit West
Bengal. Can junior members high light on Idiopathic Thrombocytopenic Purpura?? My son like Professor Dr Indranil Dutta will highlight more in this regard, You
may asl add on and share the wisdom & experiences as U completed 3 yrs in PGT . How many cases U
came acrroos such Idiopathic thrombocytopenic purpura?? My answer:-
• ITP occurs in 1 to 2 per 1,000 pregnancies
and accounts for 5% of pregnancy- associated thrombocytopenia. ITP is the most
common cause of thrombocytopenia in the first trimester. Antiplatelct
antibodies arc directed at platelet surface
glycoproteins, leading to increased
destruction of platelets by the reticuloendothelial system (primarily the
spleen) that exceeds the rate of platelet synthesis by the bone marrow. The
course of ITP is not typically affected by pregnancy.
• How to diagnose ITP??? Diagnosis: May first report with bruises
or epistaxis or bleeding from venepunture!!! Diagnosis is based complete blood count,
and peripheral smear. Women with ITP may report symptoms of easy bruising,
petechiae, epistaxis, or gingival bleeding predating pregnancy. ITP is a
diagnosis of exclusion, and there is no diagnostic test. If thrombocytopenia is
mild, it is difficult to distinguish ITP from gestational thrombocytopenia.
Detection of platelet-associated antibodies is consistent with, but not
diagnostic of, ITP because they may also be present in women with gestational
thrombocytopenia and prccclampsia. Platelet antibody testing has a fairly low
sensitivity (49% to 66%). However, the absence of platelet-associated IgG makes
the diagnosis of ITP less likely. ITP is more likely if the platelet count is
<50,000/p.L or in the presence of an underlying autoimmune disease or
history of previous thrombocytopenia. In contrast to gestational
thrombocytopenia, ITP-associated thrombocytopenia is typically evident early in
pregnancy. Findings include the following:
• Persistent thrombocytopenia (platelet
count <100,000/p.L with or without accompanying megathrombocytes on the
peripheral smear)
• Normal or increased megakaryocytes
determined from bone marrow
• Secondary causes of maternal
thrombocytopenia should be excluded (e.g., preeclampsia, HIV infection,
systemic lupus erythematosus, drugs).
• Absence of splenomegaly
• How to treat such uncommon woman in
pregancy?? When not
to transfuse blood components?? Ans:-Pregnant women with platelet counts over
50,000/p.L at any time during the pregnancy and those with counts of 30,000 to
50,000/p.L in the first or second trimester do not routinely require treatment.
If the platelet count is <10,000/pL at any point in pregnancy, between
10,000 and 30,000/pL in the second or third trimester, or if the patient
demonstrates bleeding symptoms, treatment is required. Two treatments are
available: glucocorticoids and IV gamma globulin (IVIG). What about steroids in this auto immune
diosrders like rheumatoid arthtitis or SLE ?? Glucocorticoids suppress antibody
production, inhibit sequestration of anti- body-coated platelets, and interfere
with the interaction between platelets and antibodies.
° Oral
prednisone is started at 1 to 2 mg/kg/day and is tapered to the lowest dose
supporting an acceptable platelet count (usually over 50,000/p.L) and tolerable
side effect profile. Patients usually respond within 3 to 7 days and
approximately 75% respond within 3 weeks. One fourth of patients may achieve
complete remission.° High-dose glucocorticoids, such as methylprednisolone, may
be administered at 1 to 1.5 mg/kg IV in divided doses. Very little crosses the
placenta. Response is usually seen in 2 to 10 days.
No comments:
Post a Comment